Business Context and Reporting Period
This Form 10-Q covers The Procter & Gamble Company for the quarterly period ended September 30, 2005. The Company markets approximately 300 consumer products across three global business units: P&G Beauty, P&G Family Health, and P&G Household Care. A significant corporate event occurred on October 1, 2005, with the completion of the acquisition of The Gillette Company; however, Gillette's results are not included in this quarter's financials. The Company also adopted SFAS 123(R) regarding share-based payment and changed its method of accounting for Treasury Stock effective July 1, 2005, with prior periods restated.
Key Financial Metrics
| Metric | Q1 2005 | Q1 2004 | Change |
|---|---|---|---|
| Net Sales | $14,793 million | $13,744 million | +8% |
| Operating Income | $3,057 million | $2,789 million | +10% |
| Net Earnings | $2,029 million | $1,942 million | +4% |
| Diluted EPS | $0.77 | $0.70 | +10% |
| Operating Cash Flow | $2,171 million | $1,912 million | +14% |
| Free Cash Flow | $1,770 million | $1,499 million | +18% |
| Free Cash Flow Productivity | 87% | 77% | +10 pts |
| Long-Term Debt | $21,046 million | $12,887 million (Jun 2005) | Increased |
| Cash and Equivalents | $6,310 million | $6,389 million (Jun 2005) | Decreased |
Margins: Gross margin was 51.6% (down 20 bps); Operating margin was 20.7% (up 40 bps); Net earnings margin was 13.7% (down 40 bps).
Material Changes vs. Prior Period
- Sales Growth: Net sales grew 8% driven by a 6% increase in unit volume and 1% pricing contribution. Organic sales growth was 8%. Foreign exchange contributed 1% to sales growth.
- Profitability: Operating earnings grew 10%, outpacing net earnings growth (4%). The divergence was caused by higher interest expenses ($38 million increase) related to the share repurchase program and a one-time gain in the prior year from the sale of the juice business.
- Cost Pressures: Higher commodity costs reduced gross margins by over 100 basis points. Hurricane Katrina negatively impacted operating earnings growth by approximately 2% due to coffee business disruption and asset write-offs.
- Capital Allocation: The Company repurchased $5.55 billion of common stock during the quarter, bringing cumulative repurchases under the Gillette-related plan to $8.57 billion. This was financed by a net increase in debt of $5.52 billion.
Guidance, Outlook, and Risks
Outlook and Commentary: Management expects shipment growth for Prilosec OTC to moderate in the next quarter following accelerated sales in the current period. The Company anticipates the Gillette acquisition will be reflected in results starting the quarter ending December 31, 2005. Free cash flow productivity improved to 87%, approaching the long-term target of 90%.
Risks and Contingencies:
- Integration Risk: Successful execution and integration of the Gillette merger and the Wella domination agreement.
- Commodity Costs: Continued volatility in raw material prices (e.g., pulp, natural gas, coffee beans).
- Market Conditions: Competitive activity, currency fluctuations in volatile countries, and global political/economic uncertainty.
- Legal: A pending settlement regarding air pollution standards at the Oxnard, California plant, with estimated liability not exceeding $406,000.
Investor Verification Checklist
- Accounting Changes: Verify the impact of the retrospective adoption of SFAS 123(R) on share-based compensation and the reclassification of Treasury Stock within Shareholders' Equity.
- Gillette Acquisition: Confirm the timeline for consolidating Gillette's $10.5 billion in annual sales into P&G's results (expected Q4 2005).
- Debt Structure: Review the $24 billion credit facility entered into in July 2005 to finance the share buyback program and its variable interest rate implications.
- Segment Performance: Analyze the specific impact of Hurricane Katrina on the Snacks & Coffee segment versus the strong double-digit growth in the Health Care segment.
- Share Repurchases: Monitor the remaining balance of the $18 to $22 billion share buyback authorization and the associated interest expense impact on future earnings.